Immunological treatment of multiple sclerosis. II.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007370:Interferon Type I / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000209:etiology / Q000628:therapy*; D010951:Plasma Exchange; D011241:Prednisone / Q000627:therapeutic use
D003524:Cyclosporins; D007370:Interferon Type I; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D001379:Azathioprine; D011241:Prednisone